Patents/Assignees

Immatics Biotechnologies GmbH

177 patents in portfolio

US12195506utility2025
Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
0 cites
US12195507utility2025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
0 cites
US12195508utility2025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
0 cites
US12195509utility2025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
0 cites
US12195516utility2025
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
0 cites
US12186276utility2025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
0 cites
US12186277utility2025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
0 cites
US12188932utility2025
Method for High Throughput Peptide-mhc Affinity Screening for TCR Ligands
0 cites
US12180256utility2024
Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
0 cites
US12180259utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
0 cites
US12171819utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
0 cites
US12173043utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Small Cell Lung Cancer and Other Cancers
0 cites
US12168043utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
0 cites
US12162917utility2024
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
0 cites
US12162940utility2024
BMA031 Antigen Binding Polypeptides
0 cites
US12156905utility2024
CCR8 Peptide and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
0 cites
US12150979utility2024
Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
0 cites
US12144852utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
0 cites
US12121572utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
0 cites
US12102670utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
0 cites

← PreviousPage 3 of 9Next →